We have not started testing, but forming committees and getting things started as to how this will look, educating staff and what exactly what follow up will be if exposed (what kind of testing)  Do you have anything to share that you are doing in regards to any of these things, ie.. educating staff of the HD, PPE required, testing..?

 

Thanks,

 

Angela Massey-Jenkins, BSN, RN

EOHS Clinic Coordinator

IU Health

317.962.2563 

 

From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net] On Behalf Of Angeli Mancuso
Sent: Friday, February 23, 2018 3:23 PM
To: MCOH/EH
Subject: [MCOH-EH] Hazardous drug testing

 

**** EXTERNAL Message From prvs=059253d76c=mcoh-eh-bounces@mylist.net. DO NOT open attachments or click links from unknown senders or unexpected emails. ****

Having any of you started testing based on USP 800 standards and, if so, if you receive a positive result, how are you handling any staff communication? Are there certain levels of contamination where your action plan is to clean the area but not notify staff? Are there levels that trigger staff testing?

 

So far, our testing has come back negative but the question has been raised, what do we do if we get something other than “non detected?”

 

Angeli Mancuso, RN, COHN-S/CM

Manager, Employee Health & Safety | Cottage Health

P.O Box 689 | 400 W. Pueblo St | Santa Barbara, CA 93102-0689

Office: (805) 569-7866 |  Fax: (805) 569-8271

a1mancus@sbch.org | cottagehealth.org

www.lifewhereyouloveit.org

 

 


CH Disclaimer: This electronic mail message is intended exclusively for the individual or entity to which it is addressed. This message, together with any attachment, may contain confidential and privileged information. Any views, opinions or conclusions expressed in this message are those of the individual sender and do not necessarily reflect the views of Cottage Health, its subsidiaries or affiliates. This document may also contain information covered under the Health Insurance Portability and Accountability Act (HIPAA, PL 104-191) and implementing regulations and must be protected in accordance with those provisions. Re-disclosure without patient consent or as otherwise permitted by law is prohibited. Any unauthorized review, retransmission, use, printing, copying, retention, disclosure, distribution or the taking of any action in reliance upon this information by persons or entities other than the intended recipient is strictly prohibited and may be unlawful. If you have received this message in error, please immediately advise the sender by reply email message to the sender and delete all copies of this message from your system without copying.